Paya Serai Coffee House

Slides:



Advertisements
Similar presentations
Investing in Europes health workforce of tomorrow: scope for innovation and collaboration Follow up to the Green Paper on Europes health workforce Policy.
Advertisements

Is Australia ready for ? Is Australia ready for biosimilar ? David Lim, Julie Hepworth, Lisa Nissen CC-BY,NC Sarah Macmillan.
St Hilton Irvine/Orange County Airport Irvine, California April 21, 2007 Spring 2007 Symposia Series.
ATTENDANCE FORM 6th NORTH WEST LIPID FORUM 11 th June 2013, 09: YES, I am able to attend the meeting on Tuesday 11 th June 2013 To reserve your.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
S ocial scientists are interested in how different innovative medical technologies including human tissue engineered products (HTEPs) fit into the changing.
ATTENDANCE FORM 8th NORTH WEST LIPID FORUM Wednesday 3 rd December 2014, 09: To reserve your place, please complete the form and return at your.
Explaining the Unexplained: A Bio-Psychosocial Approach to Medically Unexplained Symptoms (MUS) A One-Day Conference Beaumont Hospital Psychology Department.
ISPOR POLAND CHAPTER Polish Society of Pharmacoeconomics (PTFe )
PhAMA Position on Biosimilar Medicines Ms. Leah Goodman.
Organized by 22 nd March 2012 Time: 9am to 5pm Venue: Centre Point, Faculty of Medicine, UM Co-Joint by  games.,  mysterious gift. Ms Siti Falika Tel:
Kazakhstan: E-Government and Public Procurement Reform Capacity Building Workshop Date: May 22-23, 2006 Venue: Astana, Kazakhstan Co-hosted by: The World.
2014 UK National Lipoprotein Apheresis Conference 7 th March 2014, 09: Venue: Hilton Manchester Airport Hotel, Manchester Airport, Outwood Lane,
The Annual ARIOPS Railway Occupational Health Conference 2008 “European Challenges, Opportunities and Threats to the UK Railway Industry” Monday 30th June.
TRADITIONAL MEDICINE LANDSCAPE IN SOUTH AFRICA
Office of the Human Research Protection Program Update Sharon Friend Director /
World Congress Co-Chairs Robert Baron, MD, MS Associate Dean for Graduate and Continuing Medical Education Professor of Medicine University of California,
A 1 Closing Remarks C. Elaine Jones, Ph.D Vice President Respiratory Regulatory Affairs.
Jordan Response Plan Workshop 26 October 2014 Objectives and methodology.
WELCOME TO THE 6 th CONGRESS OF ASPIRE Jakarta 8 th -10 th, 2016.
WORKSHOP ON CUSTOMS ANKARA, 23 FEBRUARY 2005 TOBB.
Intelligent Systems TC Welcome 2014 AIAA Intelligent Systems Workshop.
IRB – Investigator/Research Coordinators Monthly Meeting Gerald D. Fischbach, M.D. Executive Vice President for Health and Biomedical Sciences and Dean.
Advanced Healthcare Technology Management Workshop Mombasa, Kenya — 9-12 August 2006 IFHE Workshop Overview Jennifer McGill, M.Eng., CCE.
2016 Teacher and Adviser Conference #uoltac16. Programme – 10.50Welcome Address Professor Mark Peel – Provost 9.50 – 10.30Key note speaker Jane.
ZiMA Congress 2015 Welcome and Opening Remarks Dr Agnes Mahomva, ZiMA President Elephant Hills -Victoria Falls, August 2015.
Midlands Rheumatology Commissioning Network (MRCN) Tuesday 24 th May Swinfen Hall, Lichfield Supported by Janssen-Cilag Ltd, Lilly UK & Novartis Ltd.
Learning Health Systems: Working at the Intersection of Research, Operations and Big Data Welcome May 5, 2017.
Latin American Physician Perspectives on Biosimilars
INTERNATIONAL NURSING SCHOLAR CONGRESS
2017 ComTech Innovation Summit in Healthcare, Austin
Annual Scientific Meeting 2017: Updates on Liver Pathology
Swedish Presidency Priorities in Better Regulation
and nutrition (PGHAN) problems in the North West of England
US Prescribers and Biosimilars Naming
Geriatric Medicine Society
SouthWestern Academic Health Network (SWAHN)
Research for our future
Introduction to Biosimilars
Mitch Morris, MD Executive Vice President OptumInsight
Housing and Ageing Linking strategy to future delivery for Scotland 2030.
Understanding Biologics
Biosimilars in RA: A Blessing or a Curse?
Annual Scientific Meeting 2018:
Median submission gap, median approval time and percentage approved as expedited for new active substances (NASs) approved by six authorities:
American Society for Microbiology UNLV Student Chapter presents
Wednesday 5th October Mary Ward House, London
Faculty Advancement, Success and Tenure (FAST)
Faculty Advancement, Success and Tenure (FAST)
Seamless Surgery Connect
Biosimilars in Hematologic Oncology
H2020 – SCREEN 1st International Workshop
The International Consortium for Personalised Medicine
Application of Biosimilars in RA IN Clinical Practice: Key Issues and Challenges  
The Rising Cost of Healthcare and Potential Impact of Biosimilars
Day 1 – programme Migration flows and challenges of southern Europe: data evidence and best practices in the EU Welcome & challenges 10:00 – 11:30 Evidence.
SCOTTISH PELVIC FLOOR NETWORK GLASGOW ROYAL CONCERT HALL
2018 SMASH Medical Curriculum
POEM Group Registration Status
Biosimilar Regulatory Issues
“Managing Prostate Cancer Survivorship”
Brownsville ISD Dual Enrollment Faculty Orientation
Welcome Mid-Term ERA-NET SusAn Projects Seminar
Office of the Human Research Protection Program Update
APEC Conference on Innovation and Trade
3rd Workshop on Non-Clinical Safety Assessment of Biopharmaceuticals “Next generation therapies” WELCOME.
Ron D. Hays August 5, 2011 (12:16-12:24pm) 6 minutes presentation + 3 minutes questions.
* 07/16/96 How a Bill Becomes a Law *.
The Get Involved Group Medicines & Community Pharmacy Wednesday 5 July 2017 Friend’s Meeting House 2pm – 5pm.
Presentation transcript:

Paya Serai Coffee House 1st National Bio-Therapeutics Congress - Putting Patient First 22 November 2014 at PJ Hilton General Agenda Start End Topic Speaker Venue 0830 0900 Registration of delegates NA Ballroom Foyer 0910 Welcome address Mr Yew Wei Tarng President, PhAMA Ballroom 0930 Opening Remarks Y. Bhg. Dato Eisah A Rahman Senior Director of Pharmacy Services Ministry of Health 1015 Evolving Regulatory Landscape & Challenges in Evaluating Biosimilars Pn. Arpah Abas Deputy Director/ Head of Biotechnology Section, National Pharmaceutical Control Bureau 1030 Coffee Break 1130 Size does Matter ? Professor João Eurico da Fonseca Head of the Rheumatology Research Unit at the Instituto de Medicina Molecular and Professor of Rheumatology and Biomedical Engineering, both part of the Faculty of Medicine, University of Lisbon, Portugal. 1215 Regulating the development and approval of biosimilar monoclonal antibodies – Considerations on some Regulatory and Clinical Topics Dr. Thomas Schreitmueller Head, Regulatory Policy, Biologics, Roche 1315 Lunch Paya Serai Coffee House 1415 Case presentation Indication extrapolation Interchangeability and substitution Biologic Qualifier – An INN proposal By: Dr. Paul Cornes, Consultant Clinical Oncologist, UK 1435 Launch of PhAMA Biosimilars Position paper Ms Leah Goodman 1st Vice-President of PhAMA 1450 1620 Breakout session & Panel Discussion See overleaf for sessions Anggerik 1 & Anggerik 2 (Second Floor) 1635 Wrap up of full day MC 1650 Closing Mr. Muru Annamalai 2nd Vice-President of PhAMA

Anggerik 1 & Anggerik 2 (Second Floor) Workshop sessions Session Speaker Topic Venue Workshop 1 Professor João Eurico da Fonseca Head of the Rheumatology Research Unit at the Instituto de Medicina Molecular and Professor of Rheumatology and Biomedical Engineering, both part of the Faculty of Medicine, University of Lisbon, Portugal. A Physician's Consideration towards Bio similars (Rheumatologist ,Gastroenterologist and Dermatologist) An interactive 1 – 1 session with physicians across the discipline to understand the common challenges ,unmet needs and factors that influence a physicians mind when deciding between an innovator biologic and a bio similar compound Anggerik 1 & Anggerik 2 (Second Floor) Workshop 2 Speaker 1: Dr. Paul Cornes Consultant Clinical Oncologist, UK Speaker 2: Dr. Paul Cornes Speaker 3: Dr. Thomas Schreitmueller Head, Regulatory Policy Biologics, Roche   20 mins: Globalization of Biosimilars 20 mins: The rising costs in healthcare - can Biosimilars help? 20 mins: The needs and challenges of Innovation in healthcare 30 mins: Q&A and comments Ballroom (First Floor)